Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Colonoscopy Bowel Preparation Drugs Market – Market Insights

Colonoscopy is an important screening test for detecting colorectal cancer. Colonoscopy is dependent on pre-procedure called as colonoscopy bowel preparation where the cleansing of colon is done in the patients undergoing colonoscopy.

The global colonoscopy bowel preparation drugs market was valued at US$ 1,574.9 million in 2018 and is expected to exhibit a CAGR of 4.9% over the forecast period (2019-2027).

Figure 1. Global Colonoscopy Bowel Preparation Drugs Market Value (US$ Mn), by Region, 2018

Colonoscopy Bowel Preparation Drugs  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2020)

The rising research and development activities is expected to boost growth of the colonoscopy bowel preparation drugs market

Colonoscopy bowel preparation drugs market is expected to witness significant growth, owing to rising research and development activities for the development of innovative bowel preparation drugs, in order to offer better products in the market. For instance, in December 2019, ColonaryConcepts LLC, a biotechnological company engaged in the development of colon preparation products, announced the Phase III clinical trial of its Edible Colonoscopy (EC) preparation used for bowel cleansing.

Colonoscopy bowel preparation drugs market is expected to witness significant growth, owing to increasing adoption of agreement and collaboration strategies by the market players. For instance, in January 2019, Norgine B.V. and KOREA PHARMA CO., LTD., a premier pharmaceutical manufacturer in Korea, entered into an exclusive license and distribution agreement in the Republic of Korea, by which Korea Pharma will commercialize and distribute Norgine’s product, PLENVU, in Korea.

The rising prevalence of colorectal cancer is further expected to bolster colonoscopy bowel preparation drugs market growth over the forecast period. For instance, according to the World Cancer Research Fund and American Institute of Cancer Research report 2018, Hungary accounts for the highest rate of colorectal cancer of 51.2 per 100,000 population in 2018.

Figure 2. Global Colonoscopy Bowel Preparation Drugs Market Share (%), by Product Type, 2019 and 2027

Colonoscopy Bowel Preparation Drugs  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2020)

Colonoscopy Bowel Preparation Drugs Market - Regional Analysis

North America held a dominant position in the global colonoscopy bowel preparation drugs market in 2018, owing to rising incidence of colorectal cancer in the region. For instance, according to the Global Cancer statistics (GLOBOCAN) published in January 2020, in the U.S., around 147,950 new cases of large bowel cancer are diagnosed annually, of which around 104,610 cases are of colon cancer and the remaining are colorectal cancer. According to the same source, around 53,200 Americans die every year due to colorectal cancer, which accounts for around 8% of all cancer deaths occurring, globally.

Moreover, Europe is expected to witness significant growth in the colonoscopy bowel preparation drugs market during the forecast period, owing to rising adoption of inorganic growth strategies such as collaborations and agreements by key players, in order to expand their geographical presence and product portfolio. For instance, in October 2017, Norgine B.V. received marketing authorization from the UK Medicines and Healthcare Regulatory Agency (MHRA) for PLENVU (NER1006) for bowel cleansing in adults prior to colonoscopy.

Key Players

Major players operating in the global colonoscopy bowel preparation drugs market include Ferring B.V., Bayer AG, Braintree, Bausch Health Companies Inc., and Norgine B.V.

Colonoscopy bowel preparation drugs are used in cleansing the colon for screening and detection of colorectal cancer. The drugs to be used for cleansing colon is classified as isosmotic agents, hyperosmotic agents, hyposmotic agents, and combination agents.  The hyposmotic agents include a low-volume PEG preparation called PEG-3350 (PEG-SD) that requires an additional electrolyte solution (sports drink) and often combined with bisacodyl.

Market Dynamics

The increasing prevalence of colon cancer is expected to propel global demand for colonoscopy bowel preparation drugs over the forecast period. For instance, according to the Global Cancer (GLOBOCAN) statistics published in January 2020, in the U.S., annually, around 147,950 new cases of large bowel cancer are diagnosed, of which around 104,610 cases are of colon cancer and the remaining are rectal cancer.

The increasing adoption of strategies such as collaborations and acquisitions by the market players is expected to drive the market growth over the forecast period. For instance, in May 2018, Sebela Pharmaceuticals, a specialty pharmaceutical company, acquired Braintree Laboratories Inc., a prescription pharmaceuticals manufacturing company, for expanding its gastroenterology product portfolio. For instance, in January 2020, Norgine B.V. entered into an exclusive license and distribution agreement with Aspen Pharmacare, a South African pharmaceutical holding company, for distribution and commercialization of PLENVU in the Republic of Southern Africa, Lesotho, Eswatini, Botswana, and Namibia.

Moreover, rising product launches by the market players is expected to propel the market growth over the forecast period. For instance, in February 2018, Ferring Pharmaceuticals launched Clenpiq, the first ready-to-drink colonoscopy preparation. Clenpiq contains stimulant laxative sodium picosulfate, and magnesium oxide and anhydrous citric acid, which forms the osmotic laxative magnesium citrate.

Key features of the study:

  • This report provides in-depth analysis of the colonoscopy bowel preparation drugs market and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2019-2027), considering 2018 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends,  regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global colonoscopy bowel preparation drugs market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as part of this study include Ferring B.V., Bayer AG, Braintree, Bausch Health Companies Inc., and Norgine B.V.
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding their future product launches, technology upgradation, market expansion, and marketing tactics
  • The global colonoscopy bowel preparation drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the colonoscopy bowel preparation drugs market

Detailed Segmentation:

  • Global Colonoscopy Bowel Preparation Drugs Market, By Drug Type:
    • Isosmotic Agents
      • High-volume Polyethylene Glycol Preparations
      • Sulfate-free PEG-ELS
      • Low-volume PEG Preparations
    • Hyposmotic Agents
    • Hyperosmotic Agents
      • Oral sodium Sulfate
      • Magnesium Citrate
      • Sodium Phosphate
    • Combination Agents
      • Sodium Picosulfate/Magnesium Citrate
      • Sodium Sulfate and SF-PEG-ELS
  • Global Colonoscopy Bowel Preparation Drugs Market, By Distribution Channel:
    • Hospitals Pharmacies
    • Retail Pharmacies
    • Others
  • Global Colonoscopy Bowel Preparation Drugs Market, By Region:
    • North America
      • By Drug Type:
        • Isosmotic Agents
          • High-volume Polyethylene Glycol Preparations
          • Sulfate-free PEG-ELS
          • Low-volume PEG Preparations
        • Hyposmotic Agents
        • Hyperosmotic Agents
          • Oral sodium Sulfate
          • Magnesium Citrate
          • Sodium Phosphate
        • Combination Agents
          • Sodium Picosulfate/Magnesium Citrate
          • Sodium Sulfate and SF-PEG-ELS
      • By Distribution Channel:
        • Hospitals Pharmacies
        • Retail Pharmacies
        • Others
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Drug Type:
        • Isosmotic Agents
          • High-volume Polyethylene Glycol Preparations
          • Sulfate-free PEG-ELS
          • Low-volume PEG Preparations
        • Hyposmotic Agents
        • Hyperosmotic Agents
          • Oral sodium Sulfate
          • Magnesium Citrate
          • Sodium Phosphate
        • Combination Agents
          • Sodium Picosulfate/Magnesium Citrate
          • Sodium Sulfate and SF-PEG-ELS
      • By Distribution Channel:
        • Hospitals Pharmacies
        • Retail Pharmacies
        • Others
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Drug Type:
        • Isosmotic Agents
          • High-volume Polyethylene Glycol Preparations
          • Sulfate-free PEG-ELS
          • Low-volume PEG Preparations
        • Hyposmotic Agents
        • Hyperosmotic Agents
          • Oral sodium Sulfate
          • Magnesium Citrate
          • Sodium Phosphate
        • Combination Agents
          • Sodium Picosulfate/Magnesium Citrate
          • Sodium Sulfate and SF-PEG-ELS
      • By Distribution Channel:
        • Hospitals Pharmacies
        • Retail Pharmacies
        • Others
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Drug Type:
        • Isosmotic Agents
          • High-volume Polyethylene Glycol Preparations
          • Sulfate-free PEG-ELS
          • Low-volume PEG Preparations
        • Hyposmotic Agents
        • Hyperosmotic Agents
          • Oral sodium Sulfate
          • Magnesium Citrate
          • Sodium Phosphate
        • Combination Agents
          • Sodium Picosulfate/Magnesium Citrate
          • Sodium Sulfate and SF-PEG-ELS
      • By Distribution Channel:
        • Hospitals Pharmacies
        • Retail Pharmacies
        • Others
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Drug Type:
        • Isosmotic Agents
          • High-volume Polyethylene Glycol Preparations
          • Sulfate-free PEG-ELS
          • Low-volume PEG Preparations
        • Hyposmotic Agents
        • Hyperosmotic Agents
          • Oral sodium Sulfate
          • Magnesium Citrate
          • Sodium Phosphate
        • Combination Agents
          • Sodium Picosulfate/Magnesium Citrate
          • Sodium Sulfate and SF-PEG-ELS
      • By Distribution Channel:
        • Hospitals Pharmacies
        • Retail Pharmacies
        • Others
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Drug Type:
        • Isosmotic Agents
          • High-volume Polyethylene Glycol Preparations
          • Sulfate-free PEG-ELS
          • Low-volume PEG Preparations
        • Hyposmotic Agents
        • Hyperosmotic Agents
          • Oral sodium Sulfate
          • Magnesium Citrate
          • Sodium Phosphate
        • Combination Agents
          • Sodium Picosulfate/Magnesium Citrate
          • Sodium Sulfate and SF-PEG-ELS
      • By Distribution Channel:
        • Hospitals Pharmacies
        • Retail Pharmacies
        • Others
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Ferring B.V*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Bayer AG
    • Braintree
    • Bausch Health Companies Inc.
    • Norgine B.V.

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Drug Type
      • Market Snippet, By Distribution Channel
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Market Trends
    • Regulatory Scenario
    • Reimbursement Scenario
    • Epidemiology
    • PEST Analysis
    • Recent Product Launch
    • Merger and Acquisition Scenario
  4. Global Colonoscopy Bowel Preparation Drugs Market, By Drug Type, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Isosmotic Agents
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • High-volume Polyethylene Glycol Preparations
        • Sulfate-free PEG-ELS
        • Low-volume PEG Preparations
    • Hyposmotic Agents
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Hyperosmotic Agents
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Oral sodium Sulfate
        • Magnesium Citrate
        • Sodium Phosphate
    • Combination Agents
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Sodium Picosulfate/Magnesium Citrate
        • Sodium Sulfate and SF-PEG-ELS
  5. Global Colonoscopy Bowel Preparation Drugs Market, By Distribution Channel, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  6. Global Colonoscopy Bowel Preparation Drugs Market, By Region, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2027
    • North America
      • Market Size and Forecast, By Drug Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Drug Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Drug Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Drug Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Market Size and Forecast, By Drug Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Drug Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  7. Competitive Landscape
    • Heat Map Analysis
    • Market Share Analysis
      • Ferring B.V.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Bayer AG
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Braintree
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Bausch Health Companies Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Norgine B.V.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
    • Analyst Views
  8. Section
    • References
    • Research Methodology
    • About Us and Sales Contact

*Browse 38 market data tables and 21 figures on "Colonoscopy Bowel Preparation Drugs Market - Global forecast to 2027”.

Frequently Asked Questions

The global colonoscopy bowel preparation drugs market is estimated to surpass US$ 2.4 Billion by 2027 .
Major players operating in the global colonoscopy bowel preparation drugs market include Ferring B.V., Bayer AG, Braintree, Bausch Health Companies Inc., and Norgine B.V.
North America is expected to hold dominant position in the colonoscopy bowel preparation drugs market over the forecast period, owing to rising product launches and approvals in the region, in terms ofcolonoscopy bowel preparation drugs.
The rising number of colorectal cancer cases is one of the major factors that is expected to propel growth of the market over the forecast period.
The global colonoscopy bowel preparation drugs market is estimated to exhibit a CAGR of 4.9% during the forecast period (2019-2027) .
Among regions, North America held a dominant position in the global colonoscopy bowel preparation drugs market in 2018 .
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner